trial

Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS)

NCTId NCT01154829
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 136 (actual)
Sponsored by University of Copenhagen
Primary completion 2014-05
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
136 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Factorial
Masking
None
Start
2008-12
Primary completion
2014-05
Eligibility
ALL · 18 Years · 45 Years

Interventions & indications

Drugs
AmisulprideAripiprazole

Sponsors

University of CopenhagenLead Sponsor
Glostrup University Hospital, CopenhagenCollaborator
Rigshospitalet, DenmarkCollaborator
Institute of Psychiatry, LondonCollaborator
UMC UtrechtCollaborator
Copenhagen Hospital CorporationCollaborator

Investigators

1
Birte Y Glenthoj, professorStudy Director

Sites

1 total
Glostrup Municipality, Denmark

Facts & assertions

4 sourced
Enrollment
136
Phase
NA
Primary Completion Date
2014-05
Status
COMPLETED
relationships
The graph out of here
drug
Amisulpride
drug
Aripiprazole
drug
lead_sponsor
University of Copenhagen
company
collaborator
Glostrup University Hospital, Copenhagen
company
Rigshospitalet, Denmark
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Birte Y Glenthoj, professor
person